Jorge Morales-Montor Selected Research

Parasitic Diseases (Parasitic Disease)

11/2021	Cysticidal effect of a pure naphthoquinone on Taenia crassiceps cysticerci.
6/2021	Tamoxifen Suppresses the Immune Response to Plasmodium berghei ANKA and Exacerbates Symptomatology.
12/2016	A non-hepatotropic parasite infection increases mortality in the acetaminophen-induced acute liver failure murine model: possible roles for IL-5 and IL-6.
2/2015	Gender-associated differential expression of cytokines in specific areas of the brain during helminth infection.
1/2014	Diethylstilbestrol exposure in neonatal mice induces changes in the adulthood in the immune response to taenia crassiceps without modifications of parasite loads.
7/2012	Sex steroids, immune system, and parasitic infections: facts and hypotheses.
7/2009	Neonatal exposure to estradiol induces resistance to helminth infection and changes in the expression of sex steroid hormone receptors in the brain and spleen in adult mice of both sexes.
1/2009	Immunoendocrine mechanisms associated with resistance or susceptibility to parasitic diseases during pregnancy.
1/2009	Neuroimmunomodulation during infectious diseases: mechanisms, causes and consequences for the host.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorge Morales-Montor Research Topics

Disease

25	Infections 03/2022 - 11/2003
13	Cysticercosis 11/2021 - 10/2002
9	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2014
9	Parasitic Diseases (Parasitic Disease) 11/2021 - 01/2009
6	Neoplasms (Cancer) 12/2020 - 01/2014
4	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2014
3	Malaria 06/2021 - 07/2015
3	Schistosomiasis (Bilharziasis) 06/2004 - 11/2003
2	Leishmaniasis 03/2022 - 01/2009
2	Eosinophilia 12/2019 - 12/2007
2	Persistent Infection 03/2018 - 01/2018
2	Mite Infestations (Mange) 04/2017 - 05/2015
2	Communicable Diseases (Infectious Diseases) 01/2017 - 01/2009
2	Necrosis 12/2016 - 07/2015
2	Inflammation (Inflammations) 01/2015 - 01/2013
2	Sleep Deprivation 01/2015 - 01/2015
2	Disease Progression 01/2014 - 02/2006
2	Amebiasis (Amoebiasis) 08/2010 - 02/2006
2	Amebic Liver Abscess 12/2007 - 02/2006
1	Body Weight (Weight, Body) 06/2021
1	Long Term Adverse Effects 01/2021
1	Parkinson Disease (Parkinson's Disease) 12/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Larva Migrans (Cutaneous Larva Migrans) 12/2019
1	Toxocariasis 03/2018
1	Cysts 01/2018
1	Cerebral Malaria 01/2018
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2016
1	Insulin Resistance 01/2016
1	Obesity 01/2016
1	Hyperglycemia 01/2016
1	Taeniasis 12/2015
1	Scabies (Sarcoptic Mange) 05/2015
1	Weight Loss (Weight Reduction) 12/2013
1	Virus Diseases (Viral Diseases) 01/2013
1	Atrophy 01/2013
1	Chronic Disease (Chronic Diseases) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 11/2009

Drug/Important Bio-Agent (IBA)

17	CytokinesIBA 02/2022 - 10/2002
9	SteroidsIBA 01/2018 - 10/2002
7	Hormones (Hormone)IBA 01/2021 - 11/2003
6	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2022 - 01/2009
6	Interleukin-6 (Interleukin 6)IBA 02/2022 - 10/2002
5	Pharmaceutical PreparationsIBA 01/2017 - 02/2006
5	Progesterone FDA LinkGeneric 10/2016 - 03/2005
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 05/2015
3	bisphenol AIBA 02/2022 - 01/2019
3	Therapeutic UsesIBA 11/2021 - 04/2017
3	Tamoxifen FDA LinkGeneric 06/2021 - 12/2007
3	Dehydroepiandrosterone (DHEA)IBA 03/2021 - 02/2006
3	Biological ProductsIBA 12/2020 - 05/2015
3	InterleukinsIBA 01/2020 - 12/2007
3	Messenger RNA (mRNA)IBA 01/2018 - 06/2004
3	Estradiol (Delestrogen)FDA LinkGeneric 11/2009 - 03/2005
3	Protein Isoforms (Isoforms)IBA 07/2009 - 03/2005
2	Endocrine DisruptorsIBA 02/2022 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 12/2020
2	Environmental Pollutants (Pollutants, Environmental)IBA 02/2022 - 12/2020
2	Immunologic Factors (Immunomodulators)IBA 06/2021 - 01/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020 - 01/2019
2	Estrogens (Estrogen)FDA Link 12/2020 - 01/2019
2	AntibodiesIBA 01/2020 - 12/2019
2	Estrogen ReceptorsIBA 01/2019 - 07/2009
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 01/2014
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 12/2007
2	VaccinesIBA 07/2015 - 05/2015
2	AntigensIBA 01/2013 - 01/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005 - 06/2004
2	Interleukin-1beta (Interleukin 1 beta)IBA 06/2004 - 11/2003
1	salicylhydroxamic acid (SHAM)IBA 03/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2022
1	Salivary Proteins and PeptidesIBA 03/2022
1	Tryptases (Tryptase)IBA 03/2022
1	PlasticizersIBA 01/2022
1	NaphthoquinonesIBA 11/2021
1	LigandsIBA 01/2021
1	estradiol 3-benzoate (estradiol benzoate)IBA 12/2020
1	MicroplasticsIBA 10/2020
1	Immunoglobulin M (IgM)IBA 01/2019
1	ProlactinIBA 01/2018
1	Inflammation MediatorsIBA 01/2018
1	EndocannabinoidsIBA 01/2017
1	CannabinoidsIBA 01/2017
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 12/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2016
1	Interleukin-5 (Interleukin 5)IBA 12/2016
1	Alanine Transaminase (SGPT)IBA 12/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Ivermectin (Mectizan)FDA Link 05/2015
1	Volatile Oils (Essential Oils)IBA 05/2015
1	AcaricidesIBA 05/2015
1	HLA-DR Antigens (HLA-DR)IBA 01/2015
1	ChemokinesIBA 01/2014
1	Chemokine ReceptorsIBA 01/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2013

Therapy/Procedure

3	Therapeutics 05/2015 - 01/2011
2	Hypophysectomy 03/2018 - 01/2013
1	Immunomodulation 01/2018
1	Castration 07/2015